Article
IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis.
Genes and immunity - 1 Apr 2012
Hazlett J, Stamp L K, Merriman T, Highton J, Hessian P A
Abstract excerpt
The interleukin (IL)-17/IL-23 axis is an important pro-inflammatory pathway in rheumatoid arthritis (RA). IL-23 maintains CD4(+) T-helper 17 (Th(17)) cells, whereas IL-12 negates IL-17A production by promoting Th(1)-cell differentiation. We sought evidence for any effect of polymorphisms within the interleukin-23 receptor (IL-23R), IL-12 or IL-21 genes on serum cytokine concentrations in 81 patients with RA....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
